Craft

Australian Clinical Labs

Stock Price

$3.6

2024-10-04

Market Capitalization

$754.9 M

2024-10-04

Revenue

$741.3 M

FY, 2025

Australian Clinical Labs Summary

Company Summary

Overview
Australian Clinical Labs is a pathology services provider. It offers clinical lab services, cardiac testing, drug and alcohol testing, advanced, chemical, cytopathology, haematology, histopathology, immunology, serology and microbiology, veterinary pathology, and other services. The company caters to doctors, specialists, patients, hospitals, and corporate clients.
Type
Public
Status
Active
Founded
2015
HQ
Oakleigh East, AU | view all locations
Website
https://www.clinicallabs.com.au
Cybersecurity rating
Sectors

Key People

  • Melinda McGrath

    Melinda McGrath, Chief Executive Officer, Executive Director

    • Anthony Friedli

      Anthony Friedli, Chief Operating Officer and Victoria CEO

    • James Davison

      James Davison, Chief Financial Officer

    • Sean Jackson

      Sean Jackson, Chief Information Officer

    Operating MetricsView all

    Accredited Laboratories (NATA)

    76
    5.0%

    FY, 2022

    Approved Collection Centres

    1.3K
    35.2%

    FY, 2022

    Hospitals Served

    90

    FY, 2022

    LocationsView all

    1 location detected

    • Oakleigh East, VIC HQ

      Australia

      1868 Dandenong Rd

    Australian Clinical Labs Financials

    Summary Financials

    Revenue (H1, 2026)
    $365.4M
    Gross profit (H1, 2026)
    $302.2M
    Net income (H1, 2026)
    $5.7M
    Cash (H1, 2026)
    $22.4M
    EBIT (H1, 2026)
    $19.7M
    Enterprise value
    $804.7M

    Footer menu